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Abstract. We have previously shown that the multi- 
drug resistance protein (MRP) mediates the ATP- 
dependent membrane transport of glutathione S-conju- 
gates and additional amphiphilic organic anions. In the 
present study we demonstrate the expression of MRP 
in hepatocytes where it functions in hepatobiliary ex- 
cretion. Analysis by reverse transcription-PCR of hu- 
man and normal rat liver mRNA resulted in two ex- 
pected cDNA fragments of MRP. Four different 
antibodies against MRP reacted on immunoblots with 
the glycoprotein of about 190 kD from human canalicu- 
lar as well as basolateral hepatocyte membrane prepa- 
rations. A polyclonal antibody directed against the 
carboxy-terminal sequence of MRP detected the rat 
homolog of MRP in liver. Double immunofluorescence 
microscopy and confocal laser scanning microscopy 
showed the presence of human MRP and rat Mrp in 
the canalicular as well as in the lateral membrane 
domains of hepatocytes. 
The transport function of the mrp gene-encoded 
conjugate export pump was assayed in plasma mem- 
brane vesicles with leukotriene C4 as a high-affinity 
glutathione S-conjugate substrate. The deficient ATP- 
dependent conjugate transport in canalicular mem- 
branes from TR- mutant rat hepatocytes was associ- 
ated with a lack of amplification of one of the mrp 
cDNA fragments and with a selective loss of Mrp on 
immunoblots of canalicular membranes. Double immu- 
nofluorescence microscopy of livers from transport- 
deficient TR- mutant rats localized Mrp only to the lat- 
eral but not to the canalicular membrane. Our results 
indicate that the absence of Mrp or an isoform of Mrp 
from the canalicular membrane is the basis for the he- 
reditary defect of the hepatobiliary excretion of anionic 
conjugates by the transport-deficient hepatocyte. 
XCRETION into bile is a major pathway for the elimi- 
nation of endogenous and xenobiotic lipophilic com- 
pounds  from  the  mammalian  organism.  Drug- 
metabolizing transferases in the hepatocyte convert many 
of these compounds into amphiphilic  anionic conjugates 
with glutathione, glucuronate, or sulfate. Excretion of these 
conjugates across  the  hepatocyte canalicular  membrane 
into bile is mediated by a primary-active  ATP-dependent 
export pump  which  has  been  characterized functionally 
and termed multispecific  organic anion transporter (MOAT; 1 
Oude Elferink and Jansen, 1994), non-bile acid  organic 
anion transporter (Arias et al., 1993), glutathione S-conju- 
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1. Abbreviations used in this paper: ABC, ATP-binding cassette; BLM, ba- 
solateral membrane preparation; CM, canalicular membrane preparation; 
Dg,  desmoglein; DPPIV, dipeptidyl-peptidase IV  (CD26;  EC 3.4.14.5); 
GY, Groningen Yellow; Hu, human; LM, liver membrane preparation; 
gate export pump (Ishikawa,  1992), or leukotriene export 
pump (Keppler, 1992). The latter term refers to the endog- 
enous  glutathione  S-conjugate  leukotriene  C4  (LTC4) 
which  is  the  substrate  with the  highest  affinity for this 
transporter (Ishikawa et al., 1990; Keppler, 1992; Leier et 
al., 1994b). Neither the protein nor the gene encoding this 
ATP-dependent conjugate export pump in the hepatocyte 
canalicular membrane were previously identified. 
Our recent work in human leukemia cells overexpress- 
ing the multidrug resistance  protein (MRP) and in HeLa 
cells transfected with an MRP expression vector has dem- 
onstrated that the MRP gene encodes the ATP-dependent 
export pump for LTC  4 and structurally related conjugates 
LTC4,  leukotriene C4;  MOAT, multispecific organic anion transporter; 
MRP, human multidrug resistance protein or multidrug resistance-associ- 
ated protein; MRP, gene encoding the human multidrug resistance pro- 
tein; Mrp, rat multidrug resistance protein; mrp, gene encoding the rat 
multidrug resistance protein; TR ÷, normal Wistar rat; TR- transport-defi- 
cient Wistar rat; TTBS, TBS containing 0.05% Tween 20. 
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anionic  residues  (Jedlitschky  et  al.,  1994b;  Leier et  al., 
1994b).  This  high-affinity LTC4  export pump  has  func- 
tional properties similar to the ATP-dependent conjugate 
export  pump  in  the  hepatocyte  canalicular  membrane 
(Kobayashi et al., 1988; Ishikawa et al., 1990; Kitamura et 
al.,  1990; Akerboom et al.,  1991; Fern~indez-Checa et al., 
1992;  Keppler,  1992;  Oude  Elferink  and  Jansen,  1994). 
The functional characterization of the hepatocyte conju- 
gate export pump has been promoted and facilitated by 
the  detection of mutant  rat strains  with  a  defect in  the 
canalicular excretion of amphiphilic organic anions (Jan- 
sen et al., 1985; Kuipers et al., 1988; Takikawa et al., 1991). 
In  these  transport-deficient  (TR)  Wistar  rats  we  ob- 
served that excretion of the labeled glutathione S-conju- 
gate  LTC4 into bile was  selectively reduced to less than 
2%  of normal  and  labeled  leukotrienes accumulated  in 
liver (Huber et  al.,  1987).  Accordingly, ATP-dependent 
LTC4  transport  was  below  detectability  in  hepatocyte 
canalicular  membrane  vesicles  from  transport-deficient 
TR-  rats (Ishikawa et al.,  1990; Fern~indez-Checa et al., 
1992).  It has been suggested, however, that the sinusoidal 
efflux of glutathione S-conjugates is unaffected in the TR- 
rat hepatocytes (Oude Elferink et al., 1989). Furthermore, 
the distinct ATP-dependent canalicular export pumps for 
bile salts and amphiphilic cations functioned normally in 
the mutant TR- rats (Kitamura et al.,  1990; Mailer et al., 
1991). The selective defect of the ATP-dependent canalic- 
ular conjugate export pump in mutant TR- rats is compa- 
rable  to  the  hereditary  defect  in  the  human  Dubin- 
Johnson  syndrome  (for reviews see  Oude  Elferink  and 
Jansen,  1994;  Roy Chowdhury et al.,  1994).  The Dubin- 
Johnson-syndrome is characterized by a  selective abnor- 
mality in the excretion of conjugated anions into the bile 
canaliculus  with  chronic  conjugated  hyperbilirubinemia 
and a grossly black liver due to pigment accumulation. In 
contrast to the  findings in the polarized hepatocyte, the 
ATP-dependent conjugate export pump was fully active in 
erythrocyte membranes  from both patients with Dubin- 
Johnson syndrome and transport-deficient TR  rats (Board 
et  al.,  1992).  At  present,  the  genetic  defect  in  Dubin- 
Johnson syndrome has not been elucidated. 
The MRP gene encodes a protein of 1,531 amino acids 
belonging to the ATP-binding cassette (ABC) superfamily 
of membrane transport proteins  (Cole et al.,  1992;  Cole 
and Deeley, 1993).  Overexpression of this membrane gly- 
cophosphoprotein with a molecular mass ranging from 170 
to 195 kD results in the resistance of human tumor cells to 
a number of cytotoxic drugs (Grant et al., 1994; Zaman et 
al.,  1994; Krishnamachary et al.,  1994;  Cole et al., 1994). 
High levels of MRP mRNA have been detected in various 
tumor cells and in several normal tissues.  In liver, how- 
ever, MRP mRNA was not detected in significant amounts 
(Cole et al.,  1992;  Zaman  et al.,  1993).  In this study we 
demonstrate the expression of the MRP gene in human 
liver and of its homolog in the liver of normal and trans- 
port-deficient  TR-  rats  by  reversed  transcription-PCR 
and sequencing of cDNA fragments. Immunodetection by 
Western  blotting  and  immunofluorescence  microscopy 
show the MRP transporter in the canalicular as well as in 
the lateral hepatocyte plasma membrane domain.  In the 
canalicular, but not in the lateral membrane of transport- 
deficient TR- rat hepatocytes, Mrp, or possibly an isoform 
of Mrp, is selectively absent. This altered localization of 
Mrp explains the hereditary defect of the hepatobiliary ex- 
cretion of amphiphilic anionic conjugates in the mutants. 
Materials and Methods 
Materials 
[14,15,19,20-3H]LTC4  (4.7 TBq/mmol) was obtained from Du Pont-New 
England Nuclear (Boston, MA). Unlabeled LTC4 was from Amersham- 
Buchler (Braunschweig, FRG). ATP, 5'-AMP, aprotinin, leupeptin, pep- 
statin, 1,10-phenanthroline, and potassium creatine phosphate were pur- 
chased  from  Sigma  Chemicals  (Deisenhofen, FRG).  Creatine  kinase, 
N-[N-(L-3-trans-carboxyoxiran-2-carbonyl)-L-leucyl]-agmatine  (E64), gly- 
copeptide N-glycosidase (EC 3.5.1.52),  and DNase I  (EC 3.1.21.1)  were 
from Boehringer Mannheim (Mannheim, FRG). The mRNA isolation kit, 
the RNase inhibitor (RNasin), StrataScript  TM reverse transcriptase, Taq 
DNA  polymerase, as well  as  random  and  13-actin primers were  from 
Stratagene (Heidelberg, FRG).  Reinforced cellulose nitrate membranes 
and nitrocellulose filters (pore size 0.2  Ixm) were from Schleicher und 
Schuell (Dassel, FRG). Protein standard mixture (M  r 43,000-200,000)  was 
from  Merck  (Darmstadt,  FRG).  Ultrafree-MC  (30,000  NMWL)  filter 
units were from Millipore (Eschborn, FRG). 
Antibodies 
Polyclonal rabbit anti-MRP antisera, kindly provided by Dr. M. Center 
(Kansas State University, Manhattan, KS), were raised against three dif- 
ferent synthetic peptides near the carboxyl terminus of the deduced amino 
acid sequence of MRP (Krishnarnachary et al., 1994): 6KQ (QRGLFYS- 
MAKDAGLV; amino acids 1517-1531),  7QE (QERFIHQSDLKVDEN; 
amino acids 1171-1185),  and 8KR (RMNLDPFSQYSDEEV; amino acids 
1385-1399). 
The affinity purification of the 6KQ antiserum was performed as fol- 
lows:  membrane preparations of MRP-overexpressing HL60/ADR cells 
were subjected to 7.5% SDS-PAGE and subsequently transferred to ni- 
trocellulose membranes. Blots on nitrocellulose membranes were stained 
with  0.2%  Ponceau-S in  3%  TCA  and  the MRP  region was  excised, 
washed, and blocked for 1 h  at room temperature. Subsequently excised 
pieces were incubated for I h at room temperature with a 1:25 dilution of 
the 6KQ antiserum in TBS containing 5% BSA and 0.2% NaN  3. The 6KQ 
solution was removed and stored on ice prior to the next incubation cycle. 
The excised blot pieces were washed with PBS and bound antibodies were 
eluted by incubation of the blot pieces for 20 rain at 52°C in PBS contain- 
ing 0.2% NaN  3. The blot pieces were incubated again with the 6KQ solu- 
tion. This procedure was repeated 10 times. The eluted antibody fractions 
were pooled and concentrated (Ultrafree-MC filter units; 30,000 NWML). 
The  monoclonal antibody QCRL-1,  recognizing MRP in multidrug- 
resistant H69AR cells and MRP-transfected HeLa T5 cells (Hipfuer et al., 
1994),  was  kindly provided by  Drs.  R.  G.  Deeley and  S.  P.  C.  Cole 
(Queen's University, Kingston, Ontario,  Canada).  Monoclonal anti-rat 
dipeptidyl-peptidase IV (DPPIV) antibody De 13.4 (Becket et al., 1986) 
was kindly provided by Dr. W. Reutter (Freie Universit~it,  Berlin, FRG). 
Purified mouse  anti-human dipeptidyl-peptidase IV  (CD  26)  antibody 
was purchased from Dianova  (Hamburg, FRG).  The monoclonal anti- 
desmoglein antibody (Dg 3.10) has been described (Schmelz et al., 1986). 
The mAb antidesmoplakin I and II (2.15, 2.17, 2.19) was prepared as de- 
scribed (Cowin et al., 1985). The P-glycoprotein-reactive mAb C219 was 
from Isotopen Diagnostik CIS (Dreieich, FRG). 
Goat anti-mouse and goat anti-rabbit secondary antibodies coupled to 
FITC or Texas red were purchased from Dianova (Hamburg, FRG). Con- 
jugates of alkaline phosphatase with monoclonal anti-rabbit IgG and goat 
anti-mouse  antibodies were  from  Sigma  Chemicals.  The  conjugate  of 
horseradish peroxidase with a goat anti-mouse antibody was from Bio- 
Rad (Mtinchen, FRG). 
Tissues and Cells 
Rat Liver. Male Wistar rats (250°350  g) were obtained from Charles River 
Wiga (Sulzfeld, FRG). Male Groningen Yellow (GY) rats (Kuipers et al., 
1988), derived from the same original Wistar colony as the alternatively 
named TR- mutant rats (Jansen et al., 1985), with hepatobiliary transport 
defect for glutathione S-conjugates and structurally related amphiphilic 
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Groningen, The Netherlands). Animals were maintained on a  standard 
diet with free access to food and water. 
Human Liver and Cells. Liver  samples were  obtained  perioperatively 
from excised hepatic tissue from three patients, 30--60 yr old, who had pri- 
mary hepatocellular carcinoma or primary biliary cirrhosis. Pathological 
tissue  was  removed,  as  judged  by  macroscopic  inspection,  and  only 
healthy liver tissue was further processed. 
The MRP- (p190-) overexpressing doxorubicin (Adriamycin)-resistant 
cell line HL60/ADR has been characterized (McGrath et al., 1987; Mar- 
quardt et al., 1990; Krishnamachary et al., 1993) and was kindly provided 
by Dr. M. Center. Cells were grown in RPMI-1640 medium with 10% fe- 
tal calf serum in a humidified incubator with 5% CO2 at 37°C. 
mRNA Analysis by Reverse Transcription-PCR, 
Subcloning, and Sequencing 
Poly(A) ÷ RNA was isolated from rapidly frozen liver tissue using the 
Stratagene mRNA isolation kit according to the manufacturers instruc- 
tions. To prevent DNA contamination the mRNA samples (5 0-g) were 
pretreated with 10 U of DNase I in 50 I~l digestion buffer (100 mM sodium 
acetate, pH 5.0, 5 mM MgSO4, and 40 U of the RNAse inhibitor RNasin) 
at 37°C for i  h. After phenol/chloroform treatment and ethanol precipita- 
tion the mRNA (200 ng) was reverse transcribed in a 50 ~I transcription 
buffer (50 mM Tris, pH 8.3, 75 mM KC1, 3 mM MgC12, 10 mM DTT, 1 mM 
dNTPs, 40 U  RNasin, 300 ng of random primers) with 50 U  of Strata- 
Script  TM reverse transcriptase at 40°C for 1 h, followed by heating to 95°C 
for 5 min, and immediate cooling on ice. Reverse transcription without 
RNA template served as a negative control. 
The reverse transcription mixture (5 t~1) was amplified by PCR in 100 
o-l of buffer (10×  reaction buffer as provided by the manufacturer) with 
0.25  O-M of sense and anti-sense primers, and 2.5  U  of Taq DNA poly- 
merase. The PCR was run at 94°C for 1 min, at 56°C for 1 min, and at 72°C 
for 2 rain, for a total of 33 cycles. Amplification was terminated by a final 
incubation at 72°C for 10 min. The PCR products (9 ~tl) were separated on 
1.2% agarose gels and visualized by ethidium bromide staining. PCR ex- 
periments using mRNA not reverse transcribed were run as negative con- 
trois  to  exclude  amplification  of genomic DNA.  cDNA  derived  from 
mRNA of the MRP-overexpressing HL60/ADR ceils served as positive 
control. 
Primers for MRP gene sequences were as follows: 182-bp region sense 
primer  (ForllI),  TATGTGCCACAGCAGGCCTGGAT (bases 2,324- 
2,346), and anti-sense primer (RevIII), CCAGACAGGTrCACGCCCTTC- 
TCGCCAA  (bases  2,505-2,478);  347-bp  region  sense  primer  (ForI), 
AAGGTCGGCATIGTIGGGCGGA (bases 4,160--4,181),  and anti-sense 
primer  (RevI), AGCTGICGCTGCCCIACICT (bases 4,506-4,487).  As 
an internal control a sample of each first-strand cDNA was treated with 
primers amplifying a 661-bp fragment of human (and rat) 13-actin. This re- 
verse transcription reaction (1 Ixl) was amplified in 50 ixl of PCR initiated 
with 2 U  of Taq DNA polymerase. Amplification proceeded through 28 
cycles at 94°C for 45 s, at 60°C for 45 s, and at 72°C for 1.5 min. 
PCR fragments were cloned into the pCRII vector (Invitrogen BV, NV 
Leek, The Netherlands) and sequenced according to the Sanger method 
using the sequencing kit from Pharmacia (Freiburg, FRG). 
Plasma Membrane Vesicle Preparation 
and ATP-dependent LTC4 Transport 
Plasma Membrane Preparation. Membrane fractions enriched in canalicu- 
lar (CM) or basolateral (BLM) membrane domains from human and rat 
liver were prepared as described (Meier and Boyer, 1990; Kadmon et al., 
1993, B0hme et al., 1994).  The marker enzyme activities in our CM and 
BLM have been reported recently (Kadmon et aL, 1993;  BOhme et al., 
1994).  The contamination of rat liver CM with BLM was below 10%  as 
judged from Na+,K+-ATPase activities. The relative amounts of DPPIV 
and desmoglein in CM and BLM are shown under Results (see Fig. 5). 
Preparation of HL60/ADR plasma membrane vesicles was described 
recently (Jedlitschky et al., 1994b). All membranes were prepared in the 
presence of proteinase inhibitors (0.3 ~M aprotinin, 1 I~M leupeptin, 0.1 
mM PMSF, 1 O-M pepstatin, 2.8 O-M E64, and 5 mM 1,10-phenanthroline). 
ATP-dependent 3[H]LTC4 Transport into Membrane Vesicles. [3H]LTC4 
transport  into  membrane  vesicles  was  determined  by  rapid  filtration 
(BOhme et al., 1994; Leier et al., 1994a).  In brief, vesicles (30 ~tg of pro- 
tein) from liver plasma membranes were incubated at 37°C with 50 nM 
[3H]LTC4  in an incubation buffer containing 250 mM sucrose and t0 mM 
Tris-HC1, pH 7.4, in the presence of 4 mM ATP and an ATP-regenerating 
system. In control experiments ATP was replaced by Y-AMP. The respec- 
tive vesicle-associated [3H]LTC4  in the blanks with 5'-AMP represented 
base-line values corresponding to 2.9 _+ 0.6 pmol/mg protein in CM and 
6.1  +-  1.3  pmol/mg protein in BLM. Reduced glutathione (5 mM) was 
added to prevent binding of LTC4 to the membrane-bound glutathione 
S-transferase  as  well  as  the  degradation  of  LTC4  by  the  canalicular 
~/-glutamyltransferase. The final incubation volume was 110 o-l. Aliquots 
(20 ~1) were taken at the indicated time points and the vesicle associated 
radioactivity was determined. 
Immunodetection by Western Blotting and 
Fluorescence Microscopy 
lmmunoblotAnalysis. Membrane fractions (50 o-g of protein, unless indi- 
cated otherwise) were subjected to 7.5%  SDS-PAGE  (Laemmli, 1970), 
without boiling, and transferred to nitrocellulose membrane (Towbin et 
al., 1979).  Protein blots were blocked for 1 h at room temperature and in- 
cubated overnight at room temperature with polyclonal anti-MRP anti- 
body diluted in TBS, containing 0.05% Tween 20 (TTBS) and 5% BSA. 
As the antibodies differed in their sensitivity, they were used at the fol- 
lowing dilutions: 6KQ at 1:300, 7QE and 8KR at 1:100. After incubation 
with a 1:1,000 dilution of alkaline phosphatase conjugated to monoclonal 
anti-rabbit IgG, the blots were developed with an alkaline phosphatase 
color development kit (Bio-Rad, Mtinchen, FRG). 
For  immunodetection with the mAb QCRL-1  (Hipfner et  al.,  1994) 
blots were incubated overnight with a  1:40 dilution of QCRL-1 in TTBS 
containing 5%  BSA. The horseradish peroxidase-conjugated goat anti- 
mouse antibody was diluted 1:1,000.  Antibody binding was determined 
by enhanced chemiluminescence detection (Amersham-Buchler, Braun- 
schweig, FRG) with exposure on Hyperfilm-MP. 
Immunoblots probed for P-glycoproteins were incubated overnight at 
room temperature with a 1:200 dilution of mAb C219 in TTBS, containing 
5%  BSA, washed, probed with a  1:1,000  dilutions of an alkaline  phos- 
phatase conjugate to  goat  anti-mouse antibody,  and developed  as de- 
scribed above. 
For immunodetection of desmoglein, protein blots of human and rat 
membrane preparations were incubated for 1 h at room temperature with 
mAb Dg 3.10. A preparation of desmosomes from bovine muzzle (Gorb- 
sky et al., 1981)  and a cytoskeleton preparation (Achtst~itter et al., 1986) 
of A431 cells were analyzed for comparison. Immunodetection of DPPIV 
was performed by incubation of protein blots from rat membrane prepa- 
rations with mAb De 13.4 and protein blots from human membrane prep- 
arations were incubated with the anti-human DPPIV mAb at a 1:50 dilu- 
tion. Goat anti-mouse antibodies coupled to alkaline phosphatase served 
as secondary antibodies in a 1:1,000 dilution. 
Deglycosytation  of Membrane  Glycoproteins for lmmunoblot Analysis. 
Membrane preparations (300 p.g of protein) were pelleted for 20 min at 
100,000 g at 4°C and resuspended in 40 o-1 of 10 mM Tris-HCl, pH 7.4, with 
1% SDS by ultrasonication for 1 min and incubation for 30 rain at 37°C. 
The samples were diluted 1:10 with a buffer consisting of 20 mM sodium 
phosphate, pH 7.4, 5 mM EDTA, 0.5% Nonidet P-40, 0.2% sodium azide, 
proteinase inhibitors, and again incubated for 30 min at 37°C.  Samples 
were devided in two 200-o-1 aliquots, and one of them was supplemented 
with glycopeptide N-glycosidase (0.5 U). Deglycosylation was performed 
for 15 h at 37°C. Subsequently probes were diluted three times with 400 p.l 
of 10 mM Tris-HCl, pH 7.4,  concentrated with Ultrafree-MC filter units 
(30,000 NMWL) to a final volume of 50 r~l, lyophilized, and subjected to 
immunoblot analysis. 
lmmunofluorescence  Microscopy. Small pieces of rat liver were removed 
from anaesthetized animals and directly snap-frozen in isopentane pre- 
cooled in liquid nitrogen. Samples from human liver were obtained as de- 
scribed above and snap-frozen within 20 min after surgical removal. For 
single- and double-label immunofluorescence microscopy tissue sections 
(4-5 o-m) were prepared with a  cryotome (Leica; Jung CM 3000,  Nuss- 
loch, FRG), air-dried for 1-2 h and fixed for 10 min with ice-cold acetone 
(-20°C). For double-label immunofluorescence the two primary antibod- 
ies,  one  from  mouse and  one  from  rabbit,  as  well  as  the  secondary 
antibodies, one goat anti-rabbit and one goat anti-mouse, were applied si- 
multaneously. Application of the primary or secondary antibodies was for 
45-60 min. For removal of unbound antibodies the sections were washed 
several times with PBS. Before mounting the sections were finally washed 
with distilled water and  100%  ethanol at  room temperature.  Air-dried 
sections were mounted with Moviol (Hoechst, Frankfurt, FRG). Micro- 
graphs were taken with a Zeiss Axiophot (Carl Zeiss, Jena, FRG). 
For confocal laser scanning fluorescence microscopy a LSM 410 appa- 
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argon ion (488 nm)  and a helium/neon  laser (543 nm)  and was equipped 
with appropriate  filter combinations.  Prints were taken from optical sec- 
tions of 0.8-1xm thickness. 
Results 
MRP Gene Expression in Liver 
Expression  of  the  MRP  gene  in  human  liver  and  of  the 
mrp  gene  in rat liver was analyzed  by PCR  amplification 
of cDNA  reverse transcribed  from mRNA.  PCR  amplifi- 
cation was performed  by use of primers corresponding  to 
the  sequence  of bases 2,324-2,505  and  4,160-4,506  of the 
human MRP cDNA  (Cole et al.,  1992)  in two highly con- 
served regions, as indicated by the amino acid similarity of 
62  and  66%  with the  corresponding  region  (bases  2,267- 
2,448  and  4,115-4,461)  in  the  Leishmania  ltpgpA  gene 
(Ouellette  et al., 1990).  This resulted in the expected  182- 
(primers ForIII and RevIII) and 347-bp  (primers ForI and 
RevI)  PCR  fragments  when  separated  on  agarose  gels as 
shown in Fig. 1. Both fragments were amplified and visible 
in  the  preparations  from  HL60/ADR  cells,  human  liver, 
and liver from normal Wistar (TR +) rat. However, no 347- 
bp fragment was detectable in the preparations from TR- 
mutant  rat  liver.  Subcloning  and  sequencing  of  the  182- 
and  the  347-bp  fragment  (seql; Fig.  2)  from normal TR + 
rat liver indicated  an amino acid sequence  identity of 83.3 
and  74.8%,  respectively,  when  compared  to  the  human 
MRP cDNA. 
Additional  PCR experiments using the 182-bp fragment 
Figure 1.  Analysis of MRP gene expression in human liver and 
liver from normal  (TR ÷)  and  transport-deficient  (TR-)  Wistar 
rats,  Reverse transcription was performed on mRNA with ran- 
dom primers. For PCR analysis two pairs of primers were used 
(347-  and  182-bp  fragments derived  from the  human MRP se- 
quence (Cole et al., 1992; for details see Materials and Methods). 
Lanes  !  and 2  show, as a  control, the  expression in the MRP- 
overexpressing  HL60/ADR  cells.  Both  fragments  of  the  MRP 
mRNA were detected in human liver (lanes 3 and 4), and in the 
homologous mrp mRNA in liver of TR + (lanes 5 and 6), in liver 
from TR- rats only the 182-bp fragment was detectable (lanes 7 
and  8).  Control  experiments  assaying  the  amplification  of  ge- 
nomic DNA were negative (see Materials and Methods). A  661- 
bp fragment of 13-actin cDNA,  using primers for the human se- 
quence, was run as an internal control to indicate the integrity of 
the isolated mRNA. 
A 
seql  1 
aecl2  i 
MRP  4161 
61 
61 
4220 
121 
121 
4280 
181 
181 
4340 
241 
241 
4400 
301 
301 
4460 
I0  20  30  40  50  60 
I  I  I  I 
......  •  •.  •  ..........................  •,.  ..... 
AAGGTCGGCATGGTGGGGCGGACTGGGGCT  GGGAAATCATCCCT  CACAAACTGCCTCTTC 
AAGGTTGGTATTGTGGGTCGTACAGGAGCTGGGAAATCATCTCT  CACCCTGGGTTTGTTC 
AAGGTCGGCATCGTGGGGCGGACGGGAGCTGGGAAGTCGTCCCT  GACCCTGGGCTTATTT 
•  ****  **  **  *****  **  **  **  ********  **  **  **  **  *  *  ** 
l  J  t  i 
•  °•°  ........................  .°,  •  ......... 
AGAAT C  TTAGAGT CT  GCGGGG GGC  CAGAT CAT  CAT  TGAT  GGGATAGAT  GTT  GC  C  T  C  CATT 
C  GGAT  CAAT  GAGT  CT  GCAGAAGGGGAGAT  CAT  CAT  T  GAT  GGCAT CAACAT C  GC  CAAGAT T 
C  GGAT  CAAC  GAGT  CT  GCC  GAAGGAGAGAT  CAT  CAT  C  GAT  GG  CAT  CAACAT C  GC  CAAGAT C 
•  ***  ********  *  **  **********  *****  **  *  *  ***  ** 
i  t  I  l 
....  °...  ...................................... 
GGACTGCACGACCTTCGAGAGAGGCTGACCATCATTCCC  CAGGACCCCATTTTGTT  CT  CG 
GGCCTGCACAACCTGCGCTTCAAGAT  CACCATCATTCCACAGGATCCTGTTTTGTT  CTCG 
GGCCTGCACGACCTCCGCTTCAAGAT  CACCATCAT  CCCC  CAGGACCCTGTTTTGTTTTCG 
•  *  ******  ****  **  *  *  *  ********  **  *****  **  *******  *** 
i  t  J 
,,  ......................  ,,°,  °,.,  .......... 
G  GGAGT CT  GAGGAT GAAT  CT  C  GAC  CCT  TT  CAACAAATAT  T  CAGAT GAG  GAG  GTT  T  G  GAGG 
GGTTCCCTCCGCATGAACCTGGACCCTTTCAGTCAGTATTCTGATGAAGAAGTCTGGATG 
G  GTT  C  CCT  C  C  GAAT  GAACCT GGACCCATT  CAGCCAGTACT  C  GGAT  GAAGAAGT  CT  G  GAC  G 
•  *  **  *  *****  **  *****  ****  *  **  **  *****  **  **  ****  * 
i  t  I  i 
•  .  °,°,,•  °  ......................  °  .° 
GCCCTGGAGTT  GGCTCACCTCAGATCCTTTGTGTCTGGCCTACAGCTTGGGTT  GTTAT CC 
GCTCTGGAGCTTGCTCACCTGAAGGGCTTTGTGTCAGCCTTGCCTGACAAGCT  GAACCAT 
TCCCTGGAGCTGGCCCACCTGAAGGACTTCGTGTCAGCCCTTCCTGACAAGCTAGACCAT 
•  ******  *  **  *****  *  ***  *****  *  *  *  *  *  * 
t  J  i 
...............  •  °°  ............... 
GAAGT GACAGAGG  GT  GGT  GACAAC C  T  GAG  CATAGG G  CAGAGGCAGC  T 
GAGT GT  GCAGAAG GT  GGAGAGAAT  CT  GAGT  GT  GG  G  G  CAG  C  GACAG C  T 
GAATGTGCAGAAGGCGGGGAGAACCTCAGTGTCGGGCAGCGCCAGCT 
i0  20  30  40  50  60 
I  I  I  I  I  I 
•  ,•  .•  ....................  ,..•  ,  •,, ............. 
Seql  1  KVGMVGRTGAGKSSLTNCLFRI  LESAGGQI  I  IDGI  DVASI GLHDLRERLTI  I  PQDPI LFS 
Seq2  1  KVGIVGRT  GAGKS S  LTLGLFRI NESAEGEI  I  I  DGI  N  IAKI  GLHNLRFK  IT  I  I  PQDPVLFS 
MRP  1322  KVGIVGRTGAGKSSLTLGLFRINESAEGEI  I  IDGINIAKIGLHDLRFKITI  I  PQDPVLFS 
•  **  ************  ****  ***  *  ******  .  ****  **  *******  *** 
t  ~  J  l 
o•••.• .....  •  ....  •  ....•••  .,,  •  ,  •  .......... 
61  GS  L~LDP  FN  KYS  DEEVWRALELAH  LRS  FVS  GLQLGLLS  EVT  EGGDNL S  I  GQRQ 
61  GS  LP.b~LDP  FS  QYS  DEEVWMALELAHLKGFVSALp  DKLNH ECAEGGENLSVGQRQ 
1382  GS  LRI~4LDP  FS  QYS  DEEVWTS LELAH LKDFVSALp  DKLDH ECAEGGENLSVGQRQ 
•  *********  *******  ******  ***  .  *  *  ***  ***  **** 
Figure 2.  (A) Nucleotide sequence alignment of the two different 
347-bp PCR fragments from normal TR ÷ rat liver and the human 
MRP sequence (Cole et al., 1992; these sequence data are available 
from  EMBL/Genbank/DDBS  under  accession  numbers  L05628 
(MRP), x90642 (seql), and x90643 (seq2). seql represents the se- 
quence  of  a  PCR  fragment  obtained  with  the  ForI  and  RevI 
primers, whereas seq2 exhibits the 347-bp part at the 3'-end of a 
2.2-kb PCR fragment obtained with ForlII and Revl primers. Se- 
quence identities of the seql and seq2 fragments are indicated by 
closed circles on the top line. Identities of all three sequences are 
indicated by asterisks on the bottom line. (B) Lineup of the cor- 
responding amino acid sequences.  Alignment of Seql  and  Seq2 
o  resulted in an amino acid identity of 74.8 %. The amino acid iden- 
tities for  the  Seql  and  Seq2  sequences  are  74.8  and  95.6%,  re- 
spectively,  when compared to the human MRP sequence. Align- 
ments were generated with the HUSAR program. 
sense  primer  (ForIII)  and  the  347-bp  fragment  antisense 
primer  (RevI)  resulted  in  an  expected  2.2-kb  fragment 
both in the liver of normal TR ÷ and TR- mutant rats (data 
not  shown).  Cloning  and  sequencing  of  the  2.2-kb  frag- 
ment showed  a  5'-end  sequence  which was identical  with 
the one of the 182-bp fragment in TR + and TR-  liver. In- 
terestingly, the 347-bp Y-region (seq2; Fig. 2) Of the 2.2-kb 
fragment in TR ÷ liver contained  a  somewhat different  se- 
quence  information  (95.6%  amino  acid  sequence  identity 
to  the  human  sequence;  Seq2)  than  the  one  determined 
above  for  the  347-bp  fragment  (74.8%  amino  acid  se- 
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These data provide evidence for the  presence of at least 
two  different mrp  mRNA species in  the  liver of normal 
Wistar (TR  ÷) rats. In TR- mutant liver the results are con- 
sistent either with a  loss of one mRNA species or with a 
mutation  preventing  amplification  of the  347-bp  cDNA 
fragment. Furthermore, the results are consistent with, but 
do not prove, an alternative splicing of mrp pre-mRNA. 
Immunoblot Analysis of MRP in Liver Membranes 
Western blots were performed with human liver CM and 
BLM. Protein blots were probed with three polyclonal an- 
tibodies  (6KQ,  7QE,  8KR;  see  Materials  and  Methods) 
raised  against three  different sequences  of MRP  (Krish- 
namachary et  al.,  1994)  and  with  the  mAb  QCRL-1  di- 
rected against MRP (Hipfner et al.,  1994).  Each of these 
antibodies detected a  protein of about 190 kD in human 
CM and BLM (Fig. 3). The 6KQ antibody detected, in ad- 
dition, a minor band of about 170 kD in the human BLM 
(Fig. 3). This band may correspond to an isoform differing 
in  the  length  of the  polypeptide or in glycosylation. The 
Figure 3.  Immunoblot analysis of human liver MRP in bile canal- 
icular (CM) and basolateral (BLM) membrane preparations by 
three  antibodies  raised  against  different peptide  sequences  of 
MRP and the mAb QCRL-1 directed  against MRP. Membrane 
fractions  (50 p,g of protein) were subjected  to 7.5% SDS-PAGE 
and subsequently transferred to nitrocellulose  membranes as de- 
scribed in Materials and Methods. Protein blots were probed with 
the purified polyclonal  6KQ and the monoclonal QCRL-1. For 
comparison, membranes (1  ~zg of protein) from MRP-overex- 
pressing HL60/ADR cells were probed with both antibodies  (A). 
Protein blots developed with the polyclonal antibodies  7QE and 
8KR (B) (see Materials  and Methods). 
major protein band comigrated with the MRP from HL60/ 
ADR membranes indicating that the protein of about 190 
kD is MRP expressed in human liver. 
Immunoblot  analysis  of  CM  and  BLM  from  normal 
Wistar rat liver, using the 6KQ antibody, detected a pro- 
tein of about 170-kD in both membrane fractions (Fig. 4). 
Only  the  6KQ  antibody  detected  Mrp  in  rat  liver.  This 
170-kD  protein  was  different  from  P-glycoproteins  ex- 
pressed in rat liver CM (Schrenk et al.,  1993)  as demon- 
strated  by Western  blots  already  probed  with  the  6KQ 
antibody  and  subsequently  developed  with  the  P-glyco- 
protein-reactive mAb C219  which  detected  a  protein  of 
about 150  kD (Fig. 4). Vice versa it has been shown that 
the  mAb  C219  does not  react with MRP  (Zaman et al., 
1994)  and we did not detect a  170-kD protein in rat liver 
membranes with mAb C219.  The  amount of the  190-kD 
protein in human and  of the  170-kD  protein in rat liver 
BLM was at least as high as in CM, whereas the amount of 
the  150-kD  P-glycoproteins  in  rat  BLM  was  relatively 
small. 
In addition, we studied the presence of domain-specific 
proteins  in  hepatocyte plasma membrane fractions from 
rat  and  human,  mAbs against desmoglein  (Dg),  a  trans- 
membrane  desmosomal  glycoprotein  of  the  cadherin 
family,  localized  only  in  the  lateral  membrane  domain 
(Kartenbeck et al., 1993), and DPPIV, a  canalicular (api- 
cal) membrane protein (Becket et al., 1986), were used for 
immunoblot analysis. A  significant amount of Dg was de- 
tected in BLM from human and rat liver. Only a faint band 
was detected in CM from rat and human liver (Fig. 5 A). 
Immunodetection of DPPIV revealed a significant amount 
of the protein in CM from human and rat liver and only a 
weak signal in BLM (Fig. 5 B). These data confirm the rel- 
ative purity of our  membrane preparations  and  support 
the  marker  enzyme  measurements  (see  Materials  and 
Methods). 
The 170-kD protein recognized by the polyclonal 6KQ 
antibody in rat liver membranes was considered a  candi- 
date for the rat homolog of the human MRP gene-encoded 
conjugate export pump. To further investigate this possi- 
bility, membranes were  prepared from TR-  mutant  rats 
with a  hereditary defect in the hepatobiliary excretion of 
amphiphilic  anionic  conjugates.  A  comparison  of  liver 
plasma membrane fractions from TR  ÷  and  TR-  rats  by 
immunoblot analysis with the 6KQ antibody revealed that 
there was only a very small amount of the 170-kD protein 
in CM from TR- liver when compared to CM from TR ÷ 
liver (Fig. 6). In contrast, there was no significant quantita- 
tive difference between the proteins in TR  + and TR- mu- 
tant BLM. An additional protein band migrating at about 
Figure  4.  Immunodetection 
in canalicular  (CM) and ba- 
solateral  (BLM)  hepatocyte 
membranes of rat  Mrp  and 
mdr-encoded  P-glycoproteins 
with  apparent  masses  of 
about  170  and  150  kD, 
respectively.  Blots  were  de- 
veloped with  the 6KQ antibody,  directed  against  the carboxyl 
terminus of MRP, and subsequently  stained with the P-glycopro- 
tein-reactive mAb C219. Membrane protein amounted to 50 ~g 
of protein (see Materials  and Methods). 
Mayer et al. Localization of Conjugate Export  Pump in Liver  141 Figure 5.  Immunoblot analysis of the  domain-specific antigens 
desmoglein (Dg) and dipeptidyl-peptidase  IV (DPPIV) in hepa- 
tocyte membrane  preparations. Canalicular (CM) and basolat- 
eral (BLM) membrane preparations from rat and human  liver 
(50 ~g of protein each) were subjected to SDS-PAGE and trans- 
ferred to nitrocellulose membrane. The protein blot was devel- 
oped using a desmoglein mAb. A desmosome preparation (Des) 
from bovine muzzle and a cytoskeleton preparation (CS) of A431 
cells were used for comparison (see Materials and Methods). Ar- 
rowhead points to 165 kD (A). Protein blots were performed with 
CM and BLM from rat (5 p~g of protein) and human liver (50 p,g 
of protein). The blot from the rat membranes was developed with 
the mAb De 13.4 directed against rat DPPIV, the blot from hu- 
man  membranes  was  developed with  a  mAb  against  human 
DPPIV (see Materials and Methods). Arrowhead points to 120 
kD (B). 
180 kD was consistently detected by the 6KQ antibody in 
BLM from TR-  liver, but not in membranes from normal 
rat liver (Fig. 6). 
Deglycosylation of  MRP in Liver Membranes. The  extent 
of glycosylation of the 190-kD protein in human liver and 
Figure 6.  Immunodetection and  altered distribution of Mrp in 
canalicular (CM) and basolateral (BLM) hepatocyte membrane 
preparations from transport mutant (TR-) rats. The protein blots 
were incubated with the 6KQ antibody (see Materials and Meth- 
ods). Membranes from human liver (LM - Hu) and from MRP- 
overexpressing cells (HL60/ADR) were analyzed for comparison. 
Membrane protein amounted to 5 txg for HL60/ADR membranes 
and to 50 txg for the other samples. 
of the 170-kD protein in Wistar rat and TR- liver was ex- 
amined in membrane fractions digested with glycopeptide 
N-glycosidase and subjected to immunoblot analysis with 
the  6KQ  antibody.  In  TR ÷  and  TR-  rat  liver  CM  and 
BLM the 170-kD band shifted to about 165 kD after treat- 
ment with glycopeptide N-glycosidase, suggesting that the 
protein is only core-glycosylated. Deglycosylation of hu- 
man liver CM and BLM resulted in a shift of about 20 kD 
from about 190 kD to about 170 kD (data not shown). This 
is in  agreement  with  the  molecular mass  of  172  kD  de- 
duced  from  the  primary  amino  acid  sequence  of  MRP 
(Cole et al., 1992). 
ATP-dependent [3H]LTC4 Transport by Membrane 
Vesicles from Normal and Transport-deficient Liver 
Primary-active ATP-dependent transport of [3H]LTC4 into 
inside-out  oriented  vesicles  of  TR ÷  and  TR-  CM  and 
BLM was studied over a 2-min period (Fig. 7). Membrane 
vesicles were incubated with 50 nM [3H]LTC4 in the pres- 
ence of 4 mM ATP or 4 mM 5'-AMP. 5'-AMP served as a 
control to differentiate between nucleotide-dependent bind- 
ing of the  substrate to  the  membrane  vesicles and  ATP- 
dependent  uptake  into  the  inside-out  oriented  vesicles. 
Transport  rates  were  calculated  from  the  difference  in 
transport in the presence of 4 mM ATP and 4 mM 5'-AMP 
measured  between  30  and  60  s.  Significant  uptake  of 
[3H]LTC4, with a transport rate of 6.8 pmol ×  mg protein  -1 
×  min -1  (100%),  was  observed  only  with  CM  vesicles 
from normal (TR ÷) Wistar liver. In the other membrane 
vesicle preparations  transport  rates  were  below  20%  of 
the rate in TR + CM (Fig. 7). 
Immunofluorescence and Confocal Laser 
Scanning Microscopy 
The localization of MRP  in intact liver tissue was visual- 
ized by immunofluorescence  microscopy on  cryosections 
of human  liver, as  well as  normal  (TR +)  and  transport- 
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Figure  7.  ATP-dependent 
transport of the endogenous 
glutathione  conjugate  LTC4 
by canalicular (c)  and baso- 
lateral (bl) membrane  vesi- 
cles  prepared  from  normal 
(TR ÷)  and  transport-defi- 
cient (TR-)  rat liver. Mem- 
brane vesicles (30 Ixg of pro- 
tein) were incubated with 50 
nM [3H]LTC4 in the presence 
of 4 mM ATP. Aliquots were 
taken  at  the  indicated time 
points and the vesicle-associ- 
ated  radioactivity was  mea- 
sured as described in Materi- 
als and  Methods.  In control 
experiments  ATP  was  re- 
placed  by  5'-AMP.  The 
ATP-dependent  uptake  was 
calculated by subtracting values obtained in the presence of 5'- 
AMP from those measured in the presence of ATP. Each point 
represents the mean from three different measurements. Vertical 
bars indicate SD. The membrane preparations were the same as 
the ones used in Fig. 6. 
The Journal of Cell Biology,  Volume 131, 1995  142 Figure 8.  Immunofluorescence (a) and confocal laser scanning micrographs (b and c) of frozen sections of human liver after reaction 
with purified anti-MRP 6KQ antibody (a) and after double-labeling using the 6KQ antibody and anti-human DPPIV antibody (b and 
c). Sinusoidal spaces are indicated (S). Immunostaining of MRP appears as fluorescent lines at lateral cell membranes. None or only 
faint reaction products are seen at basal (sinusoidal) surfaces (a). Double-labeling  demonstrates co-localization of bile canaliculi (DPPIV, 
red staining, e.g., arrowhead in c) and MRP-positive cell membranes (green staining, e.g., arrows in c) resulting in orange-yellow staining 
in the double-stained canalicular domains. Bars, 20 Ixm. 
Mayer et al. Localization of Conjugate Export Pump in Liver  143 Figure 9.  Immunofluorescence microscopy of normal rat liver after reaction with affinity-purified anti-MRP/Mrp 6KQ antibody (a and 
b), 6KQ antiserum (left inset in a, and d), desmoplakin antibody (right inset in a, and e), and anti-DPPIV antibody (c). Intense reaction 
with the purified 6KQ antibody demonstrates the distribution of Mrp at the lateral cell boundaries (a). Double-labeling of Mrp (b) and 
DPPIV (c) demonstrates that the Mrp-staining includes the structure of the bile canaliculi (arrowheads) and the total areas of the lateral 
plasma membranes (arrows). Comparable images are obtained after double-labeling of Mrp (left inset in a, and d) and of desmosomes 
bordering canalicular membranes (right inset in a, and e). Bars, 10 tzm (inset) and 20 tzm. 
Figure 10.  Immunofluorescence microscopy of rat liver from transport-deficient TR- animals after reaction with the affinity-purified 
anti-MRP/Mrp 6KQ antibody (a, b, and e), 6KQ antiserum (c), desmoplakin antibody (d), and DPPIV antibody (j'). Reaction with Mrp 
is visible at lateral plasma membranes (e.g., arrows in b, c, and e). Cross-sections reveal small fluorescence-negative gaps within the area 
of lateral plasma membranes (left and upper right arrowheads in a; arrowheads in b and e). On fiat sections these fluorescence-negative 
The Journal  of Cell Biology,  Volume 131, 1995  144 areas form elongated structures (e.g., arrowheads center and lower right in a, upper arrowheads in e). Double-label fluorescence demon- 
strates that Mrp-negative areas (arrowheads  in c-f) are flanked by desmosomal structures (arrowheads in d). Mrp negative-gaps can be 
identified as bile canalicular structures as shown by double-labeling experiments with anti-Mrp and DPPIV antibodies (arrowheads in e 
and J). Brackets in b denote basal (sinusoidal) surfaces. Bars, 20 rim. 
Mayer et al. Localization of Conjugate Export Pump in Liver  145 Figure 11.  Confocal laser scanning micrographs of frozen sections of normal (a-e) and TR- rat liver (f-h) after reaction with 6KQ anti- 
Mrp (red staining in a-c, p,, green staining in d, e and g, h), anti-DPPIV (green staining a-c, f) and anti-desmoplakin antibodies (red stain- 
ing in d, e and g, h). Note that in normal rat liver the red Mrp staining of the lateral cell membranes is turned into orange-yellow in the 
co-localization areas with green DPPIV reaction product (a-c). Double-labeling  of Mrp (green staining; d and e) with desmosomes bor- 
dering bile canalicular structures (red staining; d and e) demonstrate the expression of Mrp in lateral as well as in bile canalicular mem- 
branes. In the TR- mutant, Mrp (red staining in f, green staining in g and h) negative gaps are decorated with DPPIV reaction products 
(green staining in f) or are flanked by reaction products with desmoplakin antibody (red staining in g and h) leaving the Mrp-negative 
gap unstained. Arrows point to cross-sectioned lateral plasma membranes, arrowheads point to canalicular membranes. Bars, 10 ~m. 
The Journal  of Cell Biology,  Volume 131, 1995  146 Figure 12.  Scheme of the localization  of human MRP  and rat 
Mrp  in  hepatocyte  membrane domains.  In  both  species,  this 
membrane transport protein is present in the lateral membrane 
domain but not detectable in the basal  (sinusoidal)  domain.  In 
the transport-deficient TR- rat hepatocyte Mrp is not detectable 
in the canalicular  (apical) membrane, it is present, however, in 
this domain in normal liver where it functions  in the hepatobil- 
iary excretion of conjugates.  The dotted canalicular  area in the 
normal hepatocyte suggests that the canalicular protein may rep- 
resent an isoform which is absent in the mutant hepatocyte. 
deficient (TR-) rat liver. In the three different tissues ex- 
amined  all  hepatocytes reacted  positively with  the  6KQ 
MRP antibody. The staining product was localized in the 
cell periphery forming either fluorescent lines or, less in- 
tense, slightly extended plaque structures, indicative of ei- 
ther  cross  or  tangentially  sectioned  plasma  membranes 
(see e.g., Figs. 8, 9, and 10 a). 
In order  to  distinguish  between  basal  (sinusoidal)  and 
lateral immunostaining by the MRP antibody we used an- 
tibodies  recognizing  desmosomal  proteins  to  define  the 
lateral  plasma  membrane  domain  of  hepatocytes  (Far- 
quhar and Palade, 1963; Franke et al., 1981,  1982; Schwarz 
et at., 1990; Kartenbeck and Franke, 1993).  Double-label- 
ing  experiments  with  antibodies  directed  against  des- 
moplakin (Cowin et al., 1985)  and MRP (Krishnamachary 
et  al.,  1994)  revealed  that  MRP  was  present  laterally 
where desmosomal structures are located as well. This co- 
localization was consistent  for human liver (not  shown), 
for normal rat liver (Fig. 9 a, insets; d and e), as well as for 
the transport-deficient TR- mutant liver (Fig. 10, c and d). 
Basal hepatocyte plasma membranes showed no obvious 
reaction with MRP antibodies  (see e.g., brackets on Fig. 
10 b). 
The  canalicular  membrane  domain  of human  and  rat 
(TR  + and TR-) liver was further identified by the appro- 
priate anti-human and anti-rat DPPIV antibodies (Figs. 8, 
b  and c; 9 c; 10 f; 11, a-c, and j~.  Double-labeling experi- 
ments  using  antibodies  against  MRP/Mrp  and  DPPIV 
demonstrated  that  the  Mrp-staining  along lateral  plasma 
membranes includes the bile canalicular membranes in the 
normal (TR+), but not in the transport-deficient TR- mu- 
tant liver (Figs. 9, b and c; 10, c and d). 
Desmosomes were concentrated close to the canalicular 
membrane as shown by double-label fluorescence micros- 
copy (see e.g., Fig.  9,  d  and e). This close association of 
desmosomes and canalicular areas (see especially Fig. 10, c 
and d for cross-sectioned bile canaliculi) allowed the iden- 
tification  of  the  limited  area  of  the  canalicular  plasma 
membrane on  sections  stained  simultaneously with  anti- 
bodies against MRP and desmoplakin. The canalicular do- 
main remained unstained in TR- mutant liver. 
These results were further confirmed for human liver, as 
well as normal (TR÷), and TR- rat liver by confocal laser 
scanning  microscopy. Superimposing the  fluorescent im- 
ages of MRP/Mrp and DPPIV reaction products allowed 
the direct identification of bile canalicular membranes on 
MRP/Mrp-positive  structures  in  normal liver  (Figs.  8,  b 
and c;  11, a-c). In the canalicular domain of TR- mutant 
liver only DPPIV but not Mrp was detected  (Fig.  11  f). 
Immunoreaction with antibodies to desmosomal proteins 
and Mrp allowed, in addition,  to define the Mrp-positive 
areas as lateral plasma membranes and the indirect local- 
ization of bile canaliculi. 
Discussion 
In this study we have elucidated the molecular identity of 
the  ATP-dependent  conjugate  export pump in  liver and 
shown that it is a product of the MRP gene. This is in line 
with our previous work in extrahepatic cells demonstrat- 
ing that the primary-active ATP-dependent 190-kD export 
pump for glutathione S-conjugates and structurally related 
amphiphilic anions is encoded by the  human MRP gene 
(Leier et  al.,  1994b;  Jedlitschky et  al.,  1994b).  Based  on 
cDNA analysis by PCR (Fig. 1) and on Western blotting of 
human CM and BLM using four different antibodies (Fig. 
3)  we conclude that the  190-kD membrane glycoprotein, 
known  as  MRP  (Cole  et  al.,  1992;  Krishnamachary and 
Center,  1993;  Zaman  et  al.,  1993;  Hipfner  et  al.,  1994; 
Krishnamachary et al.,  1994),  is also expressed in human 
liver. The presence of an MRP homolog in rat liver (Mrp) 
is indicated by PCR analysis of cDNA fragments (Fig. 1), 
by sequence comparison with human MRP cDNA (Fig. 2), 
and by immunoblotting of plasma membrane proteins us- 
ing an antibody reactive with the peptide at the carboxyl 
terminus of MRP (Figs. 4 and 6). Moreover, immunofluo- 
rescence microscopy localized both human MRP and rat 
Mrp to the canalicular as well as to the lateral hepatocyte 
membrane (Figs. 8, 9, and 11). We have discovered a selec- 
tive loss of Mrp in  the  canalicular membrane of hepato- 
cytes from rats with a hereditary defect in the ATP-depen- 
dent transport of amphiphilic anionic conjugates from the 
liver into bile (Figs. 6, 7, and 10-11). This altered localiza- 
tion of Mrp in the transport-deficient hepatocyte indicates 
that the mutation in the TR- rat selectively affects the ap- 
pearance of the Mrp transporter in the canalicular mem- 
brane domain. 
Detection and Localization of the MRP Gene-encoded 
Conjugate Export Pump in Human and Rat Liver 
Our  data  on the  expression of the  MRP gene in  human 
liver (Figs. 1, 3, and 8) differ from earlier results which had 
indicated insignificant amounts of MRP mRNA in human 
liver (Cole et al., 1992; Zaman et al., 1993).  This apparent 
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transcription-PCR analysis and to the immediate freezing 
of the liver tissue prior to RNA extraction in our study. 
Moreover, previous investigations did not include  immu- 
nodetection of MRP in liver. Rat liver Mrp has an appar- 
ent molecular mass around 170 kD and is thus below the 
apparent mass of MRP in human liver which is around 190 
kD (Figs. 3, 4, and 6). Deglycosylation further reduced the 
apparent molecular mass of rat liver Mrp to about 165 kD. 
This corresponds  to  the  molecular mass observed when 
MRP-overexpressing HL60/ADR cells were grown in the 
presence  of  tunicamycin  (Krishnamachary  and  Center, 
1993)  or when MRP from transfected  human carcinoma 
cells was deglycosylated (Zaman et al., 1994). 
The localization of human MRP and rat Mrp in liver by 
immunofluorescence microscopy and double immunofluo- 
rescence labeling with confocal laser scanning microscopy 
indicated its presence in canalicular and lateral hepatocyte 
plasma membranes (Figs. 8, 9 a, 11 a). Comparative local- 
ization of MRP and Mrp with DPPIV and desmoplakin by 
double immunofluorescence labeling confirmed the  con- 
clusion that the protein is present in the canalicular as well 
as in the lateral plasma membrane domain (Figs. 8, b-c, 
9, b-e, and 11, a-e). Desmoplakins, components of the cy- 
toplasmic structure  of desmosomes, are arranged at cell- 
to-cell boundaries (see e.g., Kartenbeck and Franke, 1993; 
Kartenbeck et al.,  1993).  DPPIV is a  plasma membrane 
protein highly concentrated in the hepatocyte canalicular 
membrane (Becker et al., 1986; Hubbard et al., 1994).  The 
presence of both human MRP and rat Mrp in the lateral 
plasma membrane (Figs. 8-12) is in line with their intense 
detection on immunoblots of basolateral plasma membrane 
preparations (Figs. 3, 4, and 6). 
Function of the Conjugate Export Pump in Liver 
Conjugation  of  lipophilic  xenobiotics  and  endogenous 
compounds  with  glutathione  has  long  been  known  as  a 
prerequisite  for  their  excretion  across  the  canalicular 
membrane into bile (Combes, 1965; Wahll/inder and Sies, 
1979;  Oude Elferink et al.,  1989).  This process has been 
recognized as an ATP-dependent primary-active transport 
(Kobayashi et al., 1988; Kitamura et al., 1990; Ishikawa et 
al., 1990; Akerboom et al., 1991) which is deficient in the 
liver of TR-  or GY,  as well as Eisai  hyperbilirubinemic 
mutant rats (Fig. 7; Kitamura et al., 1990; Ishikawa et al., 
1990; Fernfindez-Checa et al., 1992).  Analyses in bile and 
transport assays in eanalicular plasma membrane vesicles 
from mutant and normal rat liver have been used to define 
the substrate specificity of this ATP-dependent transport 
system for conjugates  of lipophilic compounds with  glu- 
tathione,  glucuronate,  and  sulfate,  as  well  as  for  glu- 
tathione disulfide (for review see Oude Elferink and Jan- 
sen, 1994). The endogenous glutathione S-conjugate LTC4 
is an unmatched high-affinity substrate and competitor of 
this  ATP-dependent  transport  in  the  canalicular  mem- 
brane  from rat  (Ishikawa et al.,  1990;  Jedlitschky  et  al., 
1994a) and human hepatocytes (Kadmon et al., 1993). The 
substrate specificities of the conjugate export pump in rat 
hepatocytes and the human MRP gene-encoded pump are 
very similar (compare data in Ishikawa et al., 1990, or Ak- 
erboom  et  al.,  1991,  with  those  in  Leier  et  al.,  1994b). 
However, subtle  differences in substrate specificity must 
be  defined  after cloning  and  expression  of the  rat mrp 
cDNA. 
The important function of the MRP pump in the hepa- 
tobiliary excretion of conjugates is in accord with its local- 
ization to the canalicular membrane domain (Figs. 2, 3, 7, 
8, and 11, a-e).  Under some conditions, however, such as 
obstruction of the bile duct, the additional lateral localiza- 
tion of the conjugate export pump may be essential and 
provide a means to secrete conjugates across the lateral or 
basolateral hepatocyte membrane into the blood. This is 
illustrated by the renal elimination of leukotriene metabo- 
lites formed in hepatocytes of rats with bile duct ligation 
and in TR- mutant rats (Huber et al., 1987; Guhlmann et 
al., 1995), or by secretion of these metabolites into the ex- 
tracellular medium of hepatocytes isolated from TR- mu- 
tant  liver  (Keppler et  al.,  1992).  Moreover, the  isolated 
perfused  liver from TR-  mutant  rats secretes  about  the 
same  considerable  quantity  of  S-(2,4-dinitrophenyl)glu- 
tathione, which is formed within hepatocytes, into the per- 
fusion medium as does the normal control liver, whereas 
excretion of this conjugate into bile of the perfused TR- 
mutant liver is reduced to less than 2% of normal (Oude 
Elferink et al.,  1989).  S-(2,4-Dinitrophenyl)glutathione  is 
also secreted at a considerable rate into the extracellular 
medium  of isolated  TR-  mutant  hepatocytes and  it has 
been determined that 20%  of this conjugate are effluxed 
across the basolateral membrane domain (Oude Elferink 
et  al.,  1989,  1994).  These  observations  suggest  that  the 
Mrp  pump in  the  lateral  hepatocyte  membrane of TR- 
mutant rats is functionally active. The localization of MRP 
(and Mrp) to the lateral rather than to the basal (sinusoi- 
dal) hepatocyte plasma membrane may allow for uptake 
of compounds across the basal membrane followed by in- 
tracellular  conjugation  and  subsequent  ATP-dependent 
export across the lateral membrane, in addition to canalic- 
ular secretion. The low specific activity of ATP-dependent 
LTC  4 transport in basolateral membrane vesicle prepara- 
tions from normal and TR  mutant liver (Fig. 7) is in ap- 
parent contrast to the functional studies in isolated TR- 
mutant hepatocytes mentioned above and to the amount 
of  immunoreactive  protein  detected  in  this  membrane 
fraction (Figs. 3 and 6). This may be explained by the diffi- 
culty of formation of inside-out-oriented vesicles from lateral 
plasma membranes which are stabilized by the neighbor- 
ing lateral membrane via various intercellular junctional 
complexes and cannot form a single membrane inside-out 
vesicle. This orientation would be, however, the structural 
prerequisite for the measurement of ATP-dependent trans- 
port of labeled  LTC  4 into  the  vesicle.  Reconstitution  of 
proteins, solubilized from liver plasma membrane prepa- 
rations,  into  proteoliposomes  and  subsequent  measure- 
ment of ATP-dependent LTC4 transport has been achieved 
(Btichler et al., 1994) and may serve to determine the ac- 
tivity of the mrp gene-encoded conjugate export pump in 
basolateral membrane preparations from normal and TR- 
mutant hepatocytes. 
Altered Localization of the Mutant mrp Gene Product 
in Transport-deficient Rat Hepatocytes 
Our study provides the first example of an altered localiza- 
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and 10--12) resulting in impaired hepatobiliary excretion. 
The available evidence indicates that newly synthesized in- 
tegral canalicular membrane  glycoproteins are first trans- 
ported to the basolateral hepatocyte membrane and then 
by transcytosis  to the canalicular (apical) membrane  do- 
main (Hubbard et al., 1994; Maurice et al., 1994). Our re- 
suits in TR- mutant hepatocytes are consistent with a mu- 
tation causing the loss of one Mrp isoform containing the 
signal required for the trafficking of Mrp to the canalicular 
membrane domain. The mutation reflected by the lack of 
amplification  of the 347-bp 3'-proximal  cDNA  fragment 
(Fig. 1) may also interfere with alternative splicing of mrp 
pre-mRNA  leading to the loss of a  canalicular Mrp  iso- 
form. It is of interest in this regard that alternative splicing 
of MRP mRNA with an internal deletion of 65 amino ac- 
ids  at  the  carboxy-proximal  end  of  MRP  has  been  de- 
scribed (Flens et al., 1994). 
The functional defect in the TR-  rat mutant is consid- 
ered to be very similar to the canalicular transport defect 
in patients with Dubin-Johnson syndrome (Oude Elferink 
and Jansen, 1994; Roy Chowdhury et al., 1994). It has been 
of interest, therefore, to examine the presence  and local- 
ization  of  MRP  in  the  liver  of  patients  with  Dubin- 
Johnson syndrome.  Our recent  immunofluorescence  mi- 
croscopy  analyses  in  the  liver  from  a  patient  with  this 
syndrome indicate an altered localization of MRP similar 
as the one described above for TR- mutant liver (Karten- 
beck, J., U. Leuschner, R. Mayer, and D. Keppler; unpub- 
lished observation). The mislocalization of another member 
of the ATP-binding cassette superfamily of membrane trans- 
port proteins is the most frequent cause of cystic fibrosis 
(for review see Welsh and Smith, 1993). The AF508 mu- 
tation in the first nucleotide-binding domain of the cystic 
fibrosis  transmembrane  conductance  regulator  (CFTR) 
chloride channel results in defective processing and a fail- 
ure of the protein to localize correctly at the apical plasma 
membrane  domain  (Cheng  et  al.,  1990;  Kartner  et  al., 
1992).  The  analogy between  mislocalized  mutant CFFR, 
for instance in sweat glands (Kartner et al., 1992), and the 
altered localization of Mrp in TR- hepatocytes (Figs.  10- 
12) may be examined in more detail when the mutation in 
the TR- rat has been identified. 
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